VHL and nonpapillary renal cell carcinoma: In this study, to identify factors governing DCLK1 activation and α-promoter preference, we focused on hypoxia signaling, given the constitutive activation of hypoxia signaling in ccRCCs with VHL mutation, which accounts for over 90% of all ccRCC cases [46, 70].